2
S. Niranjani, K. Venkatachalam / Journal of Molecular Structure 1219 (2020) 128564
single quadrupole mass spectrometer with electrospray ionization
ESI) in the positive ionization mode was used for all samples.
(
Thermogravimetric (TG) and differential thermogravimetric (DTG)
analysis were carried out for ATC and also all CT-complexes using
Shimadzu TGA-50H thermal analyzer. The rate of heating of the
ꢁ
ꢀ1
sample was kept at 10 C min under nitrogen flow. Copper sulfate
pentahydrate was used as a calibration standard. High Resolution
scanning electron microscope (FESEM) was taken using the model
FEI, Quanta FEG 200. Elemental analysis was carried out using the
model PerkinElmer CHN 2400, USA elemental analyzer.
2
2
.3. Procedures
Fig. 1. Chemical structure of atorvastatin calcium (ATC).
.3.1. Synthesis of ATC-acceptors CT-complexes
1
mmol of ATC (0.1155 g) which was dissolved in 10 mL of
2
,5-dihydroxy-1,4-benzoquinone (DHBQ), quinalizarin (Quiz) and
methanol was mixed with 1 mmol of the acceptors, DHBQ, Quiz and
PA dissolved in the same solvent. They were stirred at room tem-
perature for 20 min. The obtained solid was filtered off, washed
several times with the same solvent and allowed to evaporate
slowly at room temperature. The solids were dried in vacuum un-
der anhydrous calcium chloride for 24 h. The obtained solids were
characterized spectrophotometrically and also by elemental
analysis.
picric acid (PA) as p-acceptors were synthesized and spectroscop-
ically investigated. The newly synthesized CT complexes have been
1
structurally characterized via elemental analysis; infrared (IR), H
NMR, mass and electronic absorption spectroscopy; thermal anal-
ysis; scanning electron microscopy (SEM) to interpret the behav-
iour of the interactions. Their bonding nature was determined by
the physical parameters using thermodynamic equations. Finally,
the biological activity of ATC-CT complexes were tested for their
antibacterial activities.
2
.3.2. Preparation of standard stock solutions of ATC and the
acceptors
Stock solutions of pure ATC and the acceptors namely, DHBQ,
2
. Experimental
ꢀ
3
Quiz and PA at a concentration of 5.0 ꢂ 10 M were freshly pre-
pared before the experiments by dissolving accurately weighed
amounts in the appropriate volume of methanol. All experiments
were done in dry conditions. They were sheltered from light. The
concerned standard solutions were prepared from the corre-
sponding stock solutions.
2.1. Chemicals
API atorvastatin calcium ([R-(R*,R*)]-2-(4-fluorophenyl)-b,d-
dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)
carbonyl]-1H-pyrrole-1-heptanoic acid, calcium salt (2:1),
68CaF 10; 1155.34) was gifted from Orchid Pharmaceutics,
India. Analytical grade reagents namely, DHBQ (2,5-dihydroxy-1,4-
benzoquinone, 140.09), quinalizarin (Quiz, 1,2,5,8-
tetrahydroxy-9,10-anthraquinone, C14 ; 272.21), and picric
acid (PA, 2,4,6-trinitrophenol; C ; 229.10) were purchased
C
66
H
2 4
N O
C
6
H
4
O
4
;
2.3.3. Spectrophotometric titration procedure
H
8
O
6
Photometric titration measurements were performed for the
reactions between the donor, ATC and each of the acceptors, DHBQ,
Quiz, PA at wavelengths of 355 nm, (588 and 638 nm) and 382 nm,
respectively, in methanol solutions at room temperature in order to
determine the reaction stoichiometries according to the literature
method [6e11]. The experiments were carried out with the fixed
6 3 3 7
H N O
from SigmaeAldrich, USA, and used as received. Commercially
available HPLC grade methanol was used as solvent from Fisher
Scientific Company.
ꢀ
4
concentration (1.00 mL of 5.0 ꢂ 10 M) of ATC in the varying
2.2. Instrumentation
concentration (0.25, 0.50, 0.75, 1.00, 1.50, 2.00, 2.50, 3.00, 3.50 or
ꢀ
4
4
.00 mL of 5.0 ꢂ 10 M) of the acceptors, namely, DHBQ, Quiz, PA
All electronic absorption spectra were recorded using Aglient
453 model with a diode array detector (DAD) in the range
in the same methanol solutions. 5.0 mL was fixed as the total vol-
ume of the mixture. As a result, donor:acceptor molar ratio was
maintained from 1:0.25 to 1:4. The peak absorbancies of the
formed CT-complexes were measured for all solutions in each case
and plotted as a function of the acceptor to donor molar ratio.
8
190e1100 nm with a quartz cell of 1.0 cm path length. The mid-
infrared spectra of ATC and the obtained CT-complexes were
recorded on Shimadzu, IRTracer 100 FTIR spectrophotometer with
ꢀ1
ATR mode with 45 number of scans at 2 cm resolution in the
ꢀ11
range 4000e400 cm . H NMR spectra were obtained on a Bruker
BioSpin GmbH-500 spectrometer operating at 500 MHz in 293.8 K
with a dual 5 mm probe head. H NMR data were expressed in parts
per million (ppm) using DMSO (dimethylsulfoxide, d ) as a solvent
6
and tetramethylsilane (TMS) as an internal reference. The signals
were referenced internally to the residual proton impurity in DMSO
and reported in chemical shift. LC-MS 2020 system equipped with
2.3.4. Biological assay
1
The antibacterial activities of the newly synthesized ATC-CT
complexes and the pure solvent, DMSO were tested in vitro
against Gram-positive bacteria, Eggerthella lenta (ATCC 43055) and
four Gram-negative bacteria, Enterobacter aerogenes (MTCC 111),
Alcaligenes faecalis (MTCC 3104), Klebsiella pneumoniae (MTCC 109)
Table 1
Spectroscopic data for the obtained ATC-acceptor complexes.
Complexes
Color
Absorbed wavelength (nm)
Stoichiometry (Donor:Acceptor)
[
[
[
(ATC)(DHBQ)
(ATC)(Quiz)
(ATC)(PA)
2
]
Pink
Dark Purple
Yellow
355
588, 638
382
1:2
1:2
1:2
2
]
2
]